Press releases | Medtronic

Month Year

Email alerts

Your search returned 131 results

Mar 15, 2010

Medtronic Announces Initial Results of STOP AF Clinical Trial

Safety and Effectiveness Trial Evaluated the Arctic Front(R) Cardiac CryoAblation Catheter System for the Treatment of Paroxysmal Atrial Fibrillation

MINNEAPOLIS & ATLANTA, Mar 15, 2010 (BUSINESS WIRE) -- Medtronic, Inc. (NYSE:MDT) today announced data from the STOP AF (Sustained Treatment of Paroxysmal Atrial Fibrillation) clinical trial...
Jan 28, 2010

Medtronic Announces Two Late Breaking Clinical Trials Accepted for American College of Cardiology Meeting

First Release of STOP-AF Data on Medtronic Arctic Front(R) Cryoballoon for Paroxysmal Atrial Fibrillation Patients

MINNEAPOLIS, Jan 28, 2010 (BUSINESS WIRE) -- Medtronic, Inc. (NYSE: MDT) announced today pivotal data for the Medtronic Arctic Front(R) CryoAblation Catheter System will be presented as a late...
May 23, 2006

Medtronic Annual Revenue Exceeds $11.3 Billion on Record Fourth Quarter Results; Business Unit and Geographic Balance Underscore Continued Growth

MINNEAPOLIS--(BUSINESS WIRE)--May 23, 2006--Medtronic, Inc. (NYSE:MDT): Annual Revenue of $11.3 Billion Grew 12% (13% Constant Currency Growth); Fourth Quarter Revenue of $3.1 Billion Grew 11%...
Nov 16, 2005

Medtronic Reports Second Quarter Revenue Growth of 15% and 23% Growth in Diluted EPS Before Special Items; After Special Items, as Reported Diluted EPS of $0.67 Increased 52%

MINNEAPOLIS--(BUSINESS WIRE)--Nov. 16, 2005--Medtronic, Inc. (NYSE:MDT): -- Implantable Cardioverter Defibrillator (ICD) Revenues Grew 34%; Worldwide Market Share Continued to Increase -- Spinal...
May 24, 2005

Medtronic Annual Revenues Exceed $10 Billion on Record Fourth-Quarter Revenues of $2.78 Billion; Implantable Defibrillators, Spinal Products and Insulin Pumps Fuel Growth

Medtronic, Inc. (NYSE:MDT): -- Implantable Cardioverter Defibrillator (ICD) Revenues of $682 million in the Quarter Increases Medtronic Worldwide ICD Market Share to 50 Percent -- Spinal Business...
Aug 18, 2004

Medtronic Reports 18 Percent Increase in First Quarter Net Earnings

MINNEAPOLIS--(BUSINESS WIRE)--Aug. 18, 2004-- Broad Based Growth Was Led By 31 Percent Increase In Quarterly Implantable Defibrillator Revenues Medtronic, Inc. (NYSE:MDT) today announced quarterly...
May 4, 2004

Medtronic Reports 24 Percent Rise in Fourth Quarter Revenue, Record Annual Revenues Exceed $9.0 Billion

MINNEAPOLIS--(BUSINESS WIRE)--May 24, 2004--Medtronic, Inc. (NYSE:MDT) today announced record quarterly revenues of $2.665 billion, an increase of 24.1 percent over the $2.148 billion of the...
Feb 10, 2004

MINNEAPOLIS--(BUSINESS WIRE)--Feb. 11, 2004-- Record Quarterly Performance Led by Greater Than 15 Percent Growth in Spinal, Implantable Defibrillators, Diabetes and Vascular Drawing upon the...
Nov 12, 2003

Medtronic Reports 14 Percent Growth in Second-Quarter Revenue and 56 Percent Growth in Earnings Per Share

MINNEAPOLIS--(BUSINESS WIRE)--Nov. 12, 2003-- Record Quarter Led by Continued Strong Growth in Implantable Defibrillator and Spinal Revenues, Together With Accelerated Growth in Diabetes; All...
Aug 12, 2003

Medtronic Reports 20 Percent Growth in First-Quarter Revenue and 19 Percent Growth in Earnings Per Share

MINNEAPOLIS--(BUSINESS WIRE)--Aug. 12, 2003-- Continued Strong Performances in Cardiac Rhythm Management, Spinal and Neurological Spur Growth Continuing to benefit from widespread acceptance of...

Show per page